HIGHLIGHTS
- who: Amblyomin-X and collaborators from the France Ocean University of China, China have published the research: Structural and functional properties of the Kunitz-type and C-terminal domains of Amblyomin-X supporting its antitumor activity, in the Journal: (JOURNAL)
- how: The authors investigated the highest concentrations of the Kunitz domain (100 u00b5M) in uptake studies.
- future: These results are relevant to understanding the Amblyomin-X mechanism of action which is a promising molecular entity to treat malignant tumors and opening frontiers for future experimentation for example using C-ter-derived peptides or . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.